Literature DB >> 10501548

High affinity binding of [3H]epibatidine to rat brain membranes.

D Gnädisch1, E D London, P Terry, G R Hill, A G Mukhin.   

Abstract

Several compounds, such as epibatidine, A-85380, and their analogs, have been identified recently as nAChR ligands whose affinities lie in the low picomolar range. Accurate measurement of such high affinities is fraught with certain technical difficulties, which may account for the inconsistency of previously reported affinities of epibatidine, ranging from 4 to 60 pM. Here, we demonstrate that (+/-)-[3H]epibatidine (1-500 pM) binds to a single population of sites in rat brain with KD of 8 +/- 2 pM. This affinity was confirmed in both kinetic experiments and competition assays with (+/-)-[3H]epibatidine and (-)-[3H]cytisine, which were performed under experimental conditions developed specifically for ligands with subnanomolar affinities. Variations from these conditions decreased the observed affinities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501548     DOI: 10.1097/00001756-199906030-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.

Authors:  Dustin P Brown; Dennis T Rogers; Francois Pomerleau; Kirin B Siripurapu; Manish Kulshrestha; Greg A Gerhardt; John M Littleton
Journal:  Fitoterapia       Date:  2016-04-20       Impact factor: 2.882

2.  The twin drug approach for novel nicotinic acetylcholine receptor ligands.

Authors:  Isabelle Tomassoli; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2015-06-20       Impact factor: 3.641

3.  The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.

Authors:  Christoph Eibl; Isabelle Tomassoli; Lenka Munoz; Clare Stokes; Roger L Papke; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2013-10-05       Impact factor: 3.641

Review 4.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

5.  High affinity binding of epibatidine to serotonin type 3 receptors.

Authors:  Renaldo C Drisdel; Douglas Sharp; Tricia Henderson; Tim G Hales; William N Green
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

6.  The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs.

Authors:  Christoph Eibl; Lenka Munoz; Isabelle Tomassoli; Clare Stokes; Roger L Papke; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2013-10-05       Impact factor: 3.641

7.  Cytisine-based nicotinic partial agonists as novel antidepressant compounds.

Authors:  Yann S Mineur; Christoph Eibl; Grace Young; Christopher Kochevar; Roger L Papke; Daniela Gündisch; Marina R Picciotto
Journal:  J Pharmacol Exp Ther       Date:  2009-01-22       Impact factor: 4.030

8.  Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding.

Authors:  Alexandra M Person; Gregg B Wells
Journal:  BMC Biophys       Date:  2011-11-23       Impact factor: 4.778

9.  Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation.

Authors:  Anitha P Govind; Yolanda F Vallejo; Jacob R Stolz; Jing-Zhi Yan; Geoffrey T Swanson; William N Green
Journal:  Elife       Date:  2017-07-18       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.